Aprea Therapeutics, Inc. (APRE)
0.695
-0.03
(-3.94%)
USD |
NASDAQ |
Oct 02, 16:00
0.6951
0.00 (0.00%)
After-Hours: 20:00
Aprea Therapeutics Net Income (Quarterly) : -3.591M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -3.591M |
| March 31, 2026 | -3.288M |
| December 31, 2025 | -2.456M |
| September 30, 2025 | -2.972M |
| June 30, 2025 | -3.239M |
| March 31, 2025 | -3.933M |
| December 31, 2024 | -2.895M |
| September 30, 2024 | -3.784M |
| June 30, 2024 | -3.470M |
| March 31, 2024 | -2.810M |
| December 31, 2023 | -3.443M |
| September 30, 2023 | -3.204M |
| June 30, 2023 | -3.259M |
| March 31, 2023 | -4.380M |
| Date | Value |
|---|---|
| December 31, 2022 | -2.442M |
| September 30, 2022 | -4.025M |
| June 30, 2022 | -98.26M |
| March 31, 2022 | -7.937M |
| December 31, 2021 | -7.755M |
| September 30, 2021 | -9.452M |
| June 30, 2021 | -10.25M |
| March 31, 2021 | -9.669M |
| December 31, 2020 | -15.39M |
| September 30, 2020 | -12.32M |
| June 30, 2020 | -16.37M |
| March 31, 2020 | -9.400M |
| December 31, 2019 | -13.07M |
| September 30, 2019 | -6.249M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Zymeworks, Inc. | -45.02M |
| Rhythm Pharmaceuticals, Inc. | -49.30M |
| ACADIA Pharmaceuticals, Inc. | 31.50M |
| Alnylam Pharmaceuticals, Inc. | 164.49M |
| Savara, Inc. | -40.23M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 3.591M |
| EPS Diluted (Quarterly) | -0.0671 |
| Enterprise Value | -31.89M |
| Earnings Yield | -154.9% |
| Normalized Earnings Yield | -154.95 |